Tuesday, October 20

Pfizer Says Coronavirus Vaccine Will Not Be Before Thanksgiving

  • Pfizer Announces Coronavirus Vaccine Will Not Be Before Thanksgiving
  • Information on safety and manufacture of the coronavirus vaccine is still missing
  • “To ensure public confidence … It is essential that the public understand our estimated timelines,” they said.

Pfizer announces that the coronavirus vaccine will not be available before Thanksgiving. The pharmaceutical giant said it hopes to have an authorization for emergency use before the end of the year.

Albert Bourla, CEO of Pfizer, announced in an open letter published Friday that despite the hard work of scientists, the vaccine will not be ready before November 3. This clarification comes despite the constant affirmations of President Donald Trump, who has indicated that it would be ready before the elections.

The Pfizer executive said that as soon as possible they will request an emergency authorization from the United States Food and Drug Administration.

PHOTO: Shutterstock

However, he estimated that the authorization would be processed until the third week of November, pending preliminary figures on the operation of the vaccine. These figures could arrive at the end of October.

He also said in the letter that they would collect information on the safety and manufacturing of the coronavirus vaccine.

In accordance with PennLive factors such as safety, efficacy, and manufacturing quality data are key to vaccine results.

“To ensure public trust and clear up a lot of confusion, I think it’s essential that the public understand our estimated timelines for each of these three areas,” Bourla stated.

“A key point that I would like to make clear is that the effectiveness would satisfy only one of the three requirements and, by itself, it would not be enough for us to request approval for public use,” added the director of this pharmaceutical company.

However, Pfizer will continue to “operate at the speed of science” and will have safety as the main point, according to its director, Albert Bourla.

The US Food and Drug Administration has previously noted that it takes weeks to process an emergency use authorization, PennLive reported.


Leave a Reply

Your email address will not be published. Required fields are marked *